Acute myeloid leukemia (AML) is a hematopoietic disorder characterized by numerous
cytogenetic and molecular aberrations that accounts for~ 25% of childhood leukemia …

Acute myeloid leukemia (AML) is a very heterogeneous hematological malignancy that
accounts for approximately 20% of all pediatric leukemia cases. The outcome of pediatric …

Purpose Late cardiotoxicity after pediatric acute myeloid leukemia therapy causes
substantial morbidity and mortality. The impact of early-onset cardiotoxicity on treatment …

Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients
With Acute Myeloid Leukemia: A Report From the Children’s Oncology Group - PMC Back to …

To study the prognostic relevance of rare genetic aberrations in acute myeloid leukemia
(AML), such as t (16; 21), international collaboration is required. Two different types of t (16; …

Elucidating genetic aberrations in pediatric acute myeloid leukemia (AML) provides insight
in biology and may impact on risk-group stratification and clinical outcome. This study aimed …

Etoposide is used to treat a wide range of malignant cancers, including acute myeloid
leukemia (AML) in children. Despite the use of intensive chemotherapeutic regimens …

Acute myeloid leukemia (AML) is a common hematopoietic malignancy with a generally
poor prognosis. Long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) …

Introduction: Survival rates of pediatric acute myeloid leukemia (AML) in low-and middle-
income countries (LMICs) seem extremely poor, and the available literature on the matter is …

Forkhead box (FOX) proteins are a group of transcriptional factors implicated in different
cellular functions such as differentiation, proliferation and senescence. A growing number of …